human | Q5 |
P856 | official website | https://pureprojects.ppad.man.ac.uk/portal/en/researchers/joan-chang(d9ae0c46-ce77-488e-88f7-2c1d44b2fdf8).html |
P496 | ORCID iD | 0000-0002-7283-9759 |
P69 | educated at | Imperial College London | Q189022 |
Institute of Cancer Research | Q6039999 | ||
P108 | employer | University of North Carolina at Chapel Hill | Q192334 |
University of Manchester | Q230899 | ||
Biotech Research and Innovation Centre | Q864831 | ||
P735 | given name | Joan | Q1484457 |
Joan | Q1484457 | ||
P106 | occupation | researcher | Q1650915 |
P21 | sex or gender | female | Q6581072 |
Q90269881 | Altered Structural Expression and Enzymatic Activity Parameters in Quiescent Ulcerative Colitis: Are These Potential Normalization Criteria? |
Q92453662 | Circadian control of the secretory pathway maintains collagen homeostasis |
Q34806346 | Hypoxia modulates the phenotype of osteoblasts isolated from knee osteoarthritis patients, leading to undermineralized bone nodule formation |
Q38165835 | Hypoxia-mediated metastasis |
Q35139526 | Identification of hypoxia-regulated proteins using MALDI-mass spectrometry imaging combined with quantitative proteomics |
Q37690525 | LOXL2 induces aberrant acinar morphogenesis via ErbB2 signaling |
Q37346579 | LOXL2-mediated matrix remodeling in metastasis and mammary gland involution |
Q33688524 | Pre-clinical evaluation of small molecule LOXL2 inhibitors in breast cancer |
Q39668596 | Quantification of Lung Metastases from In Vivo Mouse Models |